$0.277
+0.010 (+3.71%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MREO por análisis de gráficos similares
Alphio's MREO stock price prediction model matches the current Mereo BioPharma Group PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.28 (-0.15%). The 1-week path is $0.27 (-2.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Mereo BioPharma Group PLC?
Mereo BioPharma is not a good buy right now. The current price is $0.2525, and the stock has experienced a significant decline of 85.73% over the past year. Additionally, the RSI is at a very low 15.36, indicating oversold conditions, but this could signal further downside risk rather than a buying opportunity. The downgrade from JP Morgan highlights regulatory uncertainties that could hinder future performance, making it a risky investment at this time.
MREO cerró en $0.28 el Tuesday, tras subir +3.71%
Mereo BioPharma Group PLC (MREO) last closed at $0.2767, gaining +3.71%. These facts feed the 1-day and 1-week MREO price prediction above.
Factores de la previsión
Los factores de la previsión de Mereo BioPharma Group PLC (MREO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MREO, ordenadas por similitud.
Análisis de estacionalidad de MREO
Historically the probability of a positive September return for MREO is 46.51%. January offers the highest probability of a positive month at 55.74%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MREO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.70 | $1.89 | $1.97 | +582.68% |
| Oct 2026 | $1.65 | $1.71 | $1.84 | +518.66% |
| Nov 2026 | $1.69 | $1.75 | $1.92 | +531.12% |
| Dec 2026 | $1.80 | $1.89 | $1.93 | +583.76% |
En 2026, se proyecta que Mereo BioPharma Group PLC (MREO) oscile entre $1.65 y $1.97.
Previsión mensual de Mereo BioPharma Group PLC para 2026
En Sep de 2026, se proyecta que Mereo BioPharma Group PLC promedie $1.89, con un mínimo de $1.70 y un máximo de $1.97.
En Oct de 2026, se proyecta que Mereo BioPharma Group PLC promedie $1.71, con un mínimo de $1.65 y un máximo de $1.84.
En Nov de 2026, se proyecta que Mereo BioPharma Group PLC promedie $1.75, con un mínimo de $1.69 y un máximo de $1.92.
En Dec de 2026, se proyecta que Mereo BioPharma Group PLC promedie $1.89, con un mínimo de $1.80 y un máximo de $1.93.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.